Willingness to pay for haemodialysis among patients with chronic kidney disease in Abuja, Nigeria

Author:

Agada-Amade Yakubu Adole1,Ogbuabor Daniel Chukwuemeka1,Obikeze Eric1,Eborieme Ejemai2,Onwujekwe Obinna Emmanuel1

Affiliation:

1. University of Nigeria Enugu Campus

2. Dalhousie University

Abstract

Abstract Background Evidence of willingness to pay for renal replacement therapy is scarce in low-middle-income countries, including Nigeria's Formal Sector Social Health Insurance Programme. The study, therefore, assessed the willingness to pay for haemodialysis among chronic kidney disease patients in Abuja, Nigeria. Methods The study adopted a cross-sectional survey design. We used the contingent valuation method to estimate the maximum stated willingness to pay (WTP) for haemodialysis among end-stage renal disease (ESRD) patients. The socio-demographic characteristics and willingness to pay data were summarized using descriptive statistics. We evaluated the mean differences in respondents' WTP using Mann-Whitney and Kruskal-Wallis tests. All variables that had p < 0.25 in the bivariate analysis were included in the Generalized Linear Model (gamma with link function) to determine the predictors of the WTP for one's and another's haemodialysis. The level of significance in the final model was ρ < 0.05. Results About 88.3% and 64.8% of patients receiving haemodialysis were willing to pay for their haemodialysis and others, correspondingly. The mean annual WTP for haemodialysis for one’s and altruistic haemodialysis was USD25,999.06 and USD 1539.89, respectively. Private hospital patients were likelier to pay for their haemodialysis (β = 0.39, 95%CI: 0.21 to 0.57, p < 0.001). Patients attending public-private partnership hospitals were less likely to pay for altruistic haemodialysis than those attending public hospitals (β = -1.65, 95%CI: -2.51 to -0.79, p < 0.001). Conclusions The findings highlight the need for policies to promote affordable access to haemodialysis for all socioeconomic groups. Pre-payment mechanisms should be explored rather than out-of-pocket payments which pose financial hardships. The potential for altruistic financing strategies should also inform the redesign of funding policies to enhance equitable access.

Publisher

Research Square Platform LLC

Reference44 articles.

1. Cushioning the economic burden of chronic kidney disease for patients in LMICs: The heightened need for a government-driven financial support policy;Okoro RN;Health Policy Tech,2021

2. Kidney disease: Improving global outcomes (KDIGO) CKD work group. KDIGO 2012 clinical practice guideline for the evaluation and management of chronic kidney disease;Levin A;Kidney Int Supple,2013

3. Chronic kidney disease and cardiovascular risk in six regions of the world (ISN-KDDC): a cross-sectional study;Ene-Iordache B;Lancet Glob Health,2016

4. Burden of chronic kidney disease on the African continent: a systematic review and meta-analysis;Kaze AD;BMC Nephrol,2018

5. Arogundade FA, Esezobor CI, Okafor HU, Abdu A, Balogun RA, Effa EE, Popoola J, Bamgboye EL. Nephrology in Nigeria. In: Divino-Filho JC, Moura-Neto JA, Ronco C, editors. Nephrology worldwide. Switzerland: Springer; 2021.

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号  京ICP备18003416号-3